Patent · US Expired

Urea substituted imidazopyridines

US6720334B2 · kind B2 · utility

72Cited by
33References
40Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 4, 2003
Grant dateApr 13, 2004
Priority date
Expiry dateFeb 4, 2023

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D471/04
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Imidazopyridine compounds that contain urea or thiourea functionality at the 1-position are useful as immune response modifiers. The compounds and compositions of the invention can induce the biosynthesis of various cytokines and are useful in the treatment of a variety of conditions including viral diseases and neoplastic diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.